Showing results (41-50 of 124) with videos related to
Sort By:
Pageof 13
Seminars in Hematology|April 1, 1988
Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's diseaseF Cabanillas, W S Velasquez, P McLaughlin, et al.Blood|March 26, 1999
Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic featuresJ Rodriguez, P McLaughlin, F B Hagemeister, et al.Leukemia & Lymphoma|May 1, 1993
High-dose cytosine arabinoside in chronic lymphocytic leukemia: a clinical and pharmacologic analysisL E Robertson, R Hall, M J Keating, et al.Cancer|April 1, 1984
Combined modality therapy in Stage III and Stage IIIE diffuse large cell lymphomasW Velasquez, L M Fuller, K K Oh, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approachesA Preti, F B Hagemeister, P McLaughlin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphomaP McLaughlin, F B Hagemeister, J E Romaguera, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Stage III follicular lymphoma: durable remissions with a combined chemotherapy-radiotherapy regimenP McLaughlin, L M Fuller, W S Velasquez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1984
Clinical features and results of management of superior vena cava syndrome secondary to lymphomaR Perez-Soler, P McLaughlin, W S Velasquez, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphomaF Cabanillas, J Rodriguez-Diaz Pavón, F B Hagemeister, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up studyW S Velasquez, P McLaughlin, S Tucker, et al.Pageof 13